Anthony P Ford

This inventor holds 21 USPTO granted patents and 21 published patent applications, plus 5 CIPO patents and 4 EPO patents, primarily in Neurological Disorders. Top assignees: Afferent Pharmaceuticals, Inc., Curasen Therapeutics, Inc., Merck Sharp + Dohme Corp.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony P Ford. Retrieved from https://idiyas.com/inventor/anthony-p-ford

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 21)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 12)

EPO Patents = 4 (Patent Applications = 21)

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 34(Granted Patents)

Location History:

Palo Alto, CA (US) (2016 - 2022)
San Mateo, CA (US) (2021 - 2023)
Palto Alto, CA (US) (2023)
San Carlos, CA (US) (2023)

Company Filing History:

12 out of 12

Afferent Pharmaceuticals, Inc.

patents

8 out of 8

Curasen Therapeutics, Inc.

patents

1 out of 2,405

Merck Sharp + Dohme Corp.

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Neurological Diseases

Receptor Modulators

Pyrimidine Variants

Cough Treatment

Adrenergic Agonists

Chronic Cough

Neuronal Hypersensitivity

Compositions

Partial Agonists

Polymorphs

Methods of Use

Substituted Pyrazoles

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723038 - α-adrenergic receptor agonists and methods of use (2026-09-01),

2. 12616667 - Compositions and methods for improving neurological diseases and disorders (2026-05-05),

3. 12558325 - Methods for improving neurological diseases and disorders (2026-02-24),

4. 12448352 - Beta adrenergic agonist and methods of using the same (2025-10-21),

5. 11607395 - Methods for improving neurological diseases and disorders (2023-03-21),

6. 11591315 - Substituted pyrazole-pyrimidines, variants thereof, and uses therefore (2023-02-28),

7. 11590107 - Methods for treating neurological disorders with α-AR partial agonists (2023-02-28),

8. 11260056 - Diaminopyrimidine P2X3 and P2X2/3 receptor modulators for use in the treatment of cough (2022-03-01),

9. 11230533 - Crystalline salts and polymorphs of a P2X3 antagonist (2022-01-25),

10. 11230532 - Pyrimidines and variants thereof, and uses therefor (2022-01-25),

11. 11040944 - Beta adrenergic agonist and methods of using the same (2021-06-22),

12. 10988460 - Substituted pyrazole-pyrimidines, variants thereof, and uses therefore (2021-04-27),

13. 10947196 - Beta adrenergic agonist and methods of using the same (2021-03-16),

14. 10822311 - Pyrimidines and variants thereof, and uses therefor (2020-11-03),

15. 10676444 - Crystalline salts and polymorphs of a P2X3 antagonist (2020-06-09),

Title: The Innovative Journey of Anthony P Ford

Introduction: Anthony P Ford, a visionary inventor based in Palo Alto, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Anthony P Ford's latest patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles, a revolutionary wearable device for monitoring health metrics, and a unique blockchain technology for secure data storage.

Career Highlights: With over 20 years of experience in the tech industry, Anthony P Ford has a proven track record of turning innovative ideas into successful products. He has held key positions in renowned tech companies, leading research and development teams to create cutting-edge solutions.

Collaborations: Throughout his career, Anthony P Ford has collaborated with top engineers, designers, and scientists to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Anthony P Ford's passion for innovation and his relentless drive to push the boundaries of technology have established him as a prominent figure in the world of inventors. His dedication to creating solutions that improve lives and advance industries continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.